PBS-Bio repurposes oncology drugs to maximize revenue and patent life. Many approved and marketed oncology drugs are underperforming financially while valuable patent life is running out. The PBS-Bio team utilizes proprietary methods and world class experts to find new oncology indications and expand cancer markets.

Dustin provided venture initiation consulting services to PBS-Bio, including business model creation, financial modeling, business plan writing, and pitch deck development.